Two years after being introduced to the market, the FluMist intranasal vaccine appears to be safe for use among healthy people aged 5 to 49, according to the latest evidence
Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.